Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > routes

: Oral

or intravenous (PDA closure only)

& duration: 12-24 hours (IR BID); 24 hours (ER once-daily)

Use the filters below to narrow your results.

Topamax (IR), Trokendi XR, Qudexy XR, Eprontia (oral solution); component of Qsymia (with phentermine) (1)

[[:Category:Anticonvulsants|Anticonvulsant]] (1) · [[:Category:Migraine prophylactics|Migraine prophylactic]] (1) · [[:Category:Sodium channel blockers|Sodium channel blocker]] (1) · [[:Category:Weight loss medicines|Weight loss medicine]] (1)

None (1)

'"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"', '"`UNIQ--vote-00000026-QINU`"', '"`UNIQ--vote-00000027-QINU`"' (1)

Migraine: 25 mg PO at bedtime, titrate by 25 mg weekly to target 100 mg/day divided BID. Seizures: 25-50 mg/day, titrate weekly to 200-400 mg/day divided BID (1)

IR tablets 25, 50, 100, 200 mg; sprinkle capsules 15, 25 mg; Trokendi XR capsules 25, 50, 100, 200 mg; Qudexy XR capsules; Eprontia oral solution 25 mg/mL (1)

1600 mg/day (theoretical seizure dosing); practical use 400 mg/day for seizures, 100-200 mg/day for migraine prophylaxis (1)

Anticonvulsant effect within days at therapeutic level; migraine prophylaxis effect emerges over 2-3 months (1)

~21 hours'"`UNIQ--ref-00000028-QINU`"' (1)

~80% (oral)'"`UNIQ--ref-00000029-QINU`"' (1)

'''Substantial teratogenic risk''' including cleft lip/palate, hypospadias, and growth restriction (pregnancy registry data clear); effective contraception and pre-pregnancy counseling are required in reproductive-age patients'"`UNIQ--ref-0000002A-QINU`"' (1)

[[USLegal:Prescription only|Rx-only]] in US. Not a controlled substance'"`UNIQ--ref-0000002B-QINU`"' (1)

Showing below up to 1 result in range #1 to #1.

T

Topiramate

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"